In the News | Charles River
   
 
 
   
   

Recruiting and Retaining Participants in Early-Phase Trials
Fierce Pharma – June 9, 2009

The early-phase clinical trials stage is an exciting but stressful milestone for a compound headed toward market release. Significant effort, resources, and planning have brought the product to this point; where its benefits, properties, and potential problems will be tested in real-life circumstances will determine whether the product does indeed continue onward toward market release. 

Because so much is at stake, it is vital that clinical trials given the best opportunity to succeed. This includes rapid start-up times, prompt reporting, and the ability to ensure patient safety and retention. For this goal to be reached and an efficient and effective clinical trial carried out, it takes an exacting approach to recruitment, in-depth knowledge of participant populations, and proven retention methodology. Such implementation requires forethought, planning and ongoing commitment from the clinical research organization running the trial...Read the full article.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

(Country Code)+800.3195.3430
askcharlesriver@crl.com

view all

Events

view all
juin 14-juin 14 - Hørsholm, Denmark - Biotech Outsourcing Strategies (chemistry, manufa...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA, US

Charles River Laboratories, Inc.